SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Core Insights - SINTX Technologies, Inc. has sold its wholly-owned subsidiary, Technology Assessment and Transfer (TA&T), to Tethon Corporation, marking a strategic move to enhance financial flexibility and focus on high-growth opportunities in the medical device sector [1][2][3] Financial Impact - The divestment reduces corporate liabilities by $750,000 and lowers annual operating expenses by more than$1.7 million, improving the company's financial position [2][3] Strategic Focus - The sale aligns with SINTX's strategy to concentrate on commercializing bioceramic technologies aimed at improving patient outcomes and enhancing medical implants and devices [2][3] - The company is committed to advancing its proprietary silicon nitride-based technologies, which have been utilized in human implants since 2008, indicating confidence in its core technologies for long-term value creation [3][4]